// App-Quantinova.ai

11510 : Expanded Genomic Testing in Lung Adenocarcinoma Expands the Survival Benefit

Researchers

Presenter

  • Dara Aisner

Principal Investigators

  • Lynne D Berry

  • Eric B. Haura

  • Suresh S. Ramalingam

  • Bonnie S. Glisson

  • Mark A. Socinski

  • Saiama Naheed Waqar

  • Edward B. Garon

  • Jeremy Paul Cetnar

  • Katerina A Politi

  • Joan Schiller

  • Michael R. Rossi

  • Heidi Chen

  • John D. Minna

  • Ignacio Ivan Wistuba

  • Bruce E. Johnson

  • Mark G. Kris

  • Paul A. Bunn

  • David J. Kwiatkowski

Medical Centers

  • University of Colorado Denver School of Medicine, Aurora, CO

  • Brigham and Women's Hospital, Brookline, MA

  • Vanderbilt University, Nashville, TN

  • H. Lee Moffitt Cancer Center & Research Institute, Riverview, FL

  • Winship Cancer Institute of Emory University, Atlanta, GA

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

  • University of Pittsburgh, Pittsburgh, PA

  • Washington University in St Louis, St. Louis, MO

  • David Geffen School of Medcn at UCLA, Los Angeles, CA

  • Oregon Health and Science University, Portland, OR

  • Yale University School of Medicine, New Haven, CT

  • The University of Texas Southwestern Medical Center, Dallas, TX

  • Winship Cancer Institute of Emory University, Atlanta, GA

  • Vanderbilt-Ingram Cancer Center, Nashville, TN

  • The University of Texas Southwestern Medical Center, Dallas, TX

  • Dana-Farber Cancer Institute, Boston, MA

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • University of Colorado Cancer Center, Aurora, CO

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Lung Cancer

Biomarkers

  • AKT Serine

  • Dual specificity mitogen-activated protein kinase kinase 1

  • Anaplastic lymphoma Kinase

  • B-Raf proto-oncogene, serine/threonine kinase

  • Phosphatase and tensin homolog

  • Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform

  • Proto-oncogene tyrosine-protein kinase ROS

  • Ret Proto-Oncogene

  • Epidermal growth factor receptor

  • erb-b2 receptor tyrosine kinase 2

  • GTPase Nras

  • KRAS proto-oncogene, GTPase

  • Tumor protein p53

Drug/Treatment

  • TP53

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved